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ABSTRACT OF THE THESIS
Frontotemporal Dementia Knowledge Scale: Development and Preliminary Psychometric
Properties
by
Matthew John Wynn
Master of Arts in Psychological and Brain Sciences
Washington University in St. Louis, 2018
Brian D. Carpenter, Chair
Frontotemporal dementia (FTD) accounts for about 10 percent of dementia cases and is a
common cause of early-onset dementia. Although knowledge about the symptoms and
course of FTD has expanded in the past decade, there exists no well-validated instrument
to measure FTD knowledge. As a step toward that goal, this study sought to create a scale
to measure knowledge of FTD based on contemporary understanding of the disease.
Standard scale development methods were used to create items, and their psychometric
properties were evaluated in a sample of 174 healthcare providers and caregivers of
people with FTD. The resulting scale (Frontotemporal Dementia Knowledge Scale;
FTDKS) contains 18 items and takes approximately five minutes to complete. The
FTDKS displays good psychometric properties in terms of reliability (internal
consistency and split-half reliability) and validity (content, predictive, concurrent,
convergent, and divergent) in the current sample. The FTDKS can be used with
healthcare providers and caregivers of people with FTD to assess their knowledge in
clinical care and program evaluation. Further research is needed to examine the
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psychometric properties in more diverse samples and to evaluate its utility in educational
initiatives.
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Frontotemporal dementia (FTD) refers to a group of disorders caused by progressive and
selective degeneration of the frontal and temporal lobes of the brain (Pressman & Miller, 2014).
As a group, the FTD family of syndromes accounts for approximately 10 percent of dementia
cases, affecting 4.6 million people worldwide, with a prevalence of 15-22 per 100,000 (Bang,
Spina, & Miller, 2015; Onyike & Diehl-Schmid, 2013). FTD is the third most prevalent cause of
dementia and about as common as Alzheimer’s disease (AD) in terms of early-onset dementias
(Bang et al., 2015; Lashley et al., 2015; Vieira et al., 2013). Approximately 60 percent of people
with FTD are between the ages of 45 and 60 (Pressman & Miller, 2014). Knowledge about the
symptoms and course of FTD has expanded in the past decade, both in terms of what we know
and who knows it (Lashley et al., 2015; Nunnemann et al., 2012; Warren, Rohrer, & Rossor,
2013), yet it remains unclear to what extent healthcare providers and caregivers of people with
FTD are knowledgeable about the disease. Adequate knowledge about FTD is important for
providers, as they are the main point of contact for early detection, diagnosis, and ongoing
support (Shinagawa et al., 2016). Knowledge is also important among caregivers because they
support patients with FTD in a myriad of ways (Küçükgüçlü et al., 2017; Lima-Silva et al.,
2015). Although educational resources exist to enhance knowledge about FTD (O’Connor, 2013;
Ghoshal, 2018), to our knowledge there exist no empirical studies that examine what different
groups know about the disease, and there are no instruments to measure FTD knowledge. The
purpose of the current study was to create a scale to measure knowledge of FTD based on
contemporary understanding of the prevalence, causes, symptoms, progression, and treatment of
FTD. This new scale could be utilized in clinical care and to guide the development and
evaluation of education initiatives.

A crucial first step in FTD care management is timely and accurate diagnosis, and
knowledge among providers plays an important role in allowing that to happen. In the United
States, less than half of older adults living with dementia or their caregivers say that a physician
has diagnosed them with dementia (Bradford et al., 2009; Connolly et al., 2011) and even fewer
have a diagnosis of a dementing condition listed in their medical record (Chodosh et al., 2007;
Riley McCarten et al., 2012). This situation may occur because some providers do not recognize
the symptoms of dementia and lack other critical knowledge that could facilitate diagnosis. In the
case of FTD, in order to make an accurate diagnosis, providers need to have an understanding of
the heterogeneity of FTD presentation and progression. One person may exhibit early behavioral
changes and progress rapidly, while another may struggle more with language disruption and
decline gradually over a number of years. Identifying FTD as the cause underlying these
different patterns of symptoms can be difficult for specialist and non-specialist providers alike,
as evidenced in several studies. For example, one recent study conducted in an outpatient
memory clinic tracked the clinical progression of 97 people with later confirmed FTD and found
that nearly a quarter (22%) were not diagnosed with FTD while still alive (Landqvist Waldö et
al., 2015). Furthermore, reviewing medical records (including relevant clinical records from
other hospitals and general practitioners) in order to pinpoint symptom onset, only 14% of
people with confirmed FTD received FTD as their first diagnosis, with the majority first
diagnosed with a psychiatric disease, such as depression. The median time from symptom onset
to first FTD diagnosis was four years, with some diagnoses taking as long as 15 years. The
investigators hypothesized that providers may not be aware of the specific features of FTD and
therefore are more prone to misdiagnosis.
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Another study of people with FTD in an outpatient memory clinic found evidence of both
missed diagnosis and misdiagnosis (Shinagawa et al., 2016). Of the 247 patients whose clinician
referred them with a sole provisional diagnosis of behavioral variant FTD (bvFTD), 60% did not
have bvFTD according to specialists. Conversely, of the 313 patients diagnosed with FTD by
experts, 14% did not have any mention of FTD on their initial referral. False-positive and falsenegative diagnosis of FTD by non-specialist providers can have significant consequences, such
as medication mismanagement for people with FTD and delay to resources for caregivers
(Pressman & Miller, 2014; Warren et al., 2013). Therefore, educating physician providers about
how to identify FTD accurately is an important public health effort.
In addition, nonphysician providers such as psychologists, social workers, and nurses are
receiving increasing attention for their role in the dementia diagnostic process (Maslow &
Fortinski, 2018). These providers interact with older adults who have not had a formal evaluation
but are showing signs of cognitive impairment, and they may be closely connected with
caregivers and consequently in a position to assist with detection, diagnosis, and education about
cognitive impairment. Recent dementia care guidelines advocate for training of nonphysician
direct care providers so they can recognize the signs of dementia and understand when and how
to communicate these changes to experts, people with dementia, and their families (Wiener et al.,
2016). Likewise, the U.S. Administration for Community Living (ACL), in its dementia-capable
states and communities initiative, funded training for nonphysician staff and for professional care
providers to help them identify persons with cognitive impairment and refer them for diagnosis
and services (National Alzheimer’s and Dementia Resource Center, 2014). Knowledge of FTD,
similar to the other dementias, among nonphysician professionals is important in order to help
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patients and their families receive an accurate and timely diagnosis, as well as referrals to FTDspecific resources.
Knowledge about FTD is also important for the caregivers who support people with the
disease. FTD caregivers experience high rates of stress and burden (Lima-Silva et al., 2015),
higher than people caring for individuals with other types of dementia (Liu et al., 2017; Mioshi et
al., 2009). Several features of the disease, such as personality changes, disinhibition, and
language disruption, can make caregiving particularly challenging. Caregiving stress models
(e.g., Pearlin et al., 1990) identify a lack of knowledge as contributing to stress and educational
initiatives as moderating stress (Judge, Menne, & Whitlatch, 2010). Moreover, when asked about
their needs, FTD caregivers highlight information about FTD symptoms, effective
communication, and behavior management strategies as important (Diehl-Schmid et al., 2013).
Despite the need for education, one review cited lack of knowledge and information regarding
the disease as a major problem facing caregivers (Nunnemann et al., 2012). An FTD knowledge
scale could be used to evaluate the benefit of educational interventions as learning tools.
Moreover, it could be used to measure the relationship between disease-specific knowledge and
caregiver stress, as well as to characterize the effect of educational interventions on caregiver
quality of life and other outcomes.
National and state organizations have undertaken efforts to increase detection of
cognitive impairment and facilitate earlier and more accurate diagnosis, often by increasing
providers’ knowledge of dementia (Comas-Herrera, et al., 2016; U.S. Department of Veterans
Affairs, 2016). Similar initiatives specific to FTD will require tools to gauge knowledge of FTD
among physicians, nonphysicians, and caregivers and to guide education efforts among these
groups. To our knowledge, however, no studies have attempted to measure knowledge of FTD in
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any systematic way, nor is there a well-validated tool with which to measure FTD knowledge.
The purpose of this project was to create and validate a Frontotemporal Disease Knowledge
Scale (FTDKS) to measure knowledge of FTD based on contemporary understanding of the
disease.
Method
Development of FTDKS Items
We developed an initial set of 38 scale items by reviewing the literature for information
about frontotemporal dementia corresponding to several content domains. These content
domains (risk factors, assessment and diagnosis, symptoms, course, life impact, treatment and
management, caregiving) were adapted from similar scales measuring knowledge of Alzheimer’s
disease (Annear et al., 2015; Carpenter et al., 2009) and were used as a framework for our
literature search, ensuring content relevance and coverage. Informed by test development
guidelines (DeVellis, 2016; Kline 2005; Streiner & Norman, 2016), the research team reviewed
each item, removed those with overlapping content, and rewrote items for clarity. Despite our
effort to create items easy to understand, disease-specific terms, which may be difficult to
understand for some people, were present due to their importance to knowledge about FTD. The
resulting Flesch-Kinkaid Grade Level reading score (Kincaid et al., 1975) of 11.8 corresponds to
a twelfth-grade reading level. At the conclusion of this process, 27 potential items remained.
The 27 items were reviewed by eight experts currently working in FTD clinical research
(six physicians, one nurse practitioner, and one psychologist) who commented on accuracy,
wording, and overall content coverage. Based on their feedback, three items were removed from
the scale, seven were rewritten for clarity, and three new items were added in order to increase
content coverage. Next, two groups, one consisting of community-dwelling older adults and the

5

other graduate students in clinical psychology (n = 5 in each group), reviewed the items to
identify unclear phrasing. After each individual participant had answered all items, group
members were asked to explain what they thought each item was asking and why they responded
as they did. This “think-aloud” technique identified errors based on misunderstanding of the
question and questions that were easily answered despite a lack of knowledge regarding FTD. At
this phase, three items were removed from the scale and six were rewritten for clarity. The final
scale contained 24 items.
We adopted a 4-point Likert-type scale format, with an auxiliary “Don’t Know” option
adapted from the Dementia Knowledge Assessment Scale (DKAS; Annear et al., 2015).
Compared to a True/False response format, the 4-point scale plus Don’t Know detect a wider
range of uncertainty about each item, which more precisely reflects knowledge (Annear et al.,
2016).

Participants and Procedure
To evaluate the final items we recruited medical professionals and caregivers of people
with FTD to complete the scale, the types of people with whom the final version of the FTDKS
might be used. Characteristics of the subsamples appear in Table 1. Providers were contacted
through publicly available email addresses and snowball sampling. Primary care clinics,
Alzheimer’s Disease Research Centers, and professional organization listservs were targeted to
recruit providers from varying disciplines with varying degrees of knowledge about FTD.
Providers were sent emails containing a brief description of the study and a link to participate via
an online survey.
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With the collaboration of the Association for Frontotemporal Degeneration (AFTD),
caregivers were recruited from FTD support groups throughout the United States. Using publicly
available email addresses, 95 support group leaders were contacted, with permission of the
AFTD, and given email templates and flyers containing a brief description of the study and a link
to participate in the online survey. Support group leaders then distributed these materials to
members of their caregiver support group. Additional caregiver recruitment was conducted
through postings on the AFTD’s Facebook page and the FTD Support Forum website. Given
these methods of recruitment, it was not possible to know exactly how many emails were
forwarded to providers and caregivers we did not contact directly, and thus it was not possible to
calculate a final response rate. The online survey was hosted by Qualtrics, a secure, HIPAAcompliant platform for collecting survey data (Qualtrics, Provo, UT).

Measures
Demographics and background. Demographic items inquired about gender identity,
age, race, ethnicity, education, and occupation. Respondents also completed a series of questions
to assess experience with FTD. These questions were tailored for providers versus caregivers and
addressed practice setting, experience with FTD, current or previous FTD caregiving experience,
where they had received information and education related to FTD, and self-rated knowledge of
FTD (0 = “I’ve never heard of FTD” to 10 = “I am extremely knowledgeable about FTD”).
Objective knowledge about FTD and dementia. The Dementia Knowledge
Assessment Scale (DKAS; Annear et al., 2015) was included as a measure of general dementia
knowledge. The DKAS is a 25-item scale that uses a 4-point Likert-type scale (False, Probably
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False, Probably True, True) with an auxiliary Don’t Know option. Item content covers causes
and characteristics, communication and engagement care needs, and risk factors and health
promotion. Scores can range from 0 to 50, with higher scores indicating more accurate
knowledge about dementia. According to the original validation study, the DKAS has good
internal consistency (Spearman-Brown correlation coefficient of 0.78; alpha of 0.86), and
validity as a measure of dementia knowledge in a sample of health workers and students. The
second knowledge scale, the FTDKS, was developed as described above.
General intelligence. The Shipley Institute of Living Scale (Shipley, 1940) includes 40
progressively difficult vocabulary words. Respondents choose which of four listed words “means
the same or nearly the same” as a target word. The number of correct items is the final score,
with possible scores ranging from 0 to 40. The Shipley has good test-retest reliability (median r
= .78), internal consistency reliability (alpha = .80 in the current sample), validity as a measure
of general intelligence (median r = .71 with more formal measures of IQ such as the WAIS), and
the scale has been normed in a wide range of populations (Zachary, 1991).
Analytic Plan
The aim of the current study was to assemble a set of items that had sufficient face
validity and content coverage about FTD and a scale that had good reliability and validity. We
used descriptive statistics to investigate the utility of the 4-point response scale with the “Don’t
Know” option. Independent sample t-tests between provider and nonprovider group were used to
examine possible differences in the use of scale response options. To aid with item selection we
calculated the discrimination index and item difficulty index for each item. Internal consistency
reliability was evaluated with Cronbach’s alpha (average interitem correlation), split-half
reliability, and item-total correlations. Independent sample t-tests between provider and
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nonprovider groups and correlations between FTDKS total score and independent variables were
used to examine the predictive validity, convergent validity, concurrent validity, and divergent
validity of the FTDKS.
Results
Sample Characteristics
A small number of respondents (n = 4) were not medical professionals or did not know
anyone with FTD and were therefore removed from analysis, leaving a final sample of 174.
Respondents were grouped into two subsamples, providers and nonproviders, and their
characteristics appear in Table 1. Providers were, on average, younger, t(171)= -7.17, p < .001,
and more educated, 2(5) = 82.86, p < .001, but there were no differences between groups in
terms of gender, 2(2) = 2.99, p = .224, race, 2(5) = 7.403, p = .116, or self-rated knowledge of
FTD, t(172) = -.721, p = .472. The subsample of providers (n = 72) was comprised of
experienced (53% with eight or more years of experience) and educated (71% with doctoral
degrees) professionals from various disciplines, who had at least “some” experience treating,
diagnosing, or managing the care of people with FTD. The subsample of nonproviders (n = 102)
was made up of spouses, children, relatives, and friends, and professional caregivers of people
with FTD, the large majority of whom identified as the primary caregiver (73%).
Use of the Response Scale
A 4-point response scale was chosen over a more conventional dichotomous True/False
scale in order to increase precision. We calculated several descriptive statistics to examine
whether respondents utilized the full range of response options. For example, one respondent did
not vary in their use of the different response options (e.g., 100% of their responses were either
“True” or “False” and 0% of their responses were “Probably True,” “Probably False,” or “Don’t
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Know”), while other respondents made use of all response options. Respondents answered items
with either “True” or “False” a majority of the time (M = 69.7%, SD = 20.5%, range = 0% 100%), followed next by “Probably True” and “Probably False”(M = 23.2%, SD = 16.9%, range
= 0% - 83%), and used “Don’t Know” only occasionally (M = 7.11%, SD = 9.44%, range = 0% 46%). The use of different response options was also variable across items (see Table 2).
Providers and caregivers did not significantly differ in their use of the certain and probable
options, and providers were slightly less likely to use “Don’t Know” than caregivers, t(172) = 3.88, p < .001. Overall, it appears that most respondents made use of the full range of the scale.
Item Difficulty and Discrimination Indices
Performance of individual items was examined to identify potential items for removal.
Item difficulty and discrimination indices, described below and appearing in Table 2, are both
helpful in identifying candidates for removal. First, percent correct (difficulty index; p) was
calculated. Six items had difficulty indices above .95, indicating that at least 95% of respondents
answered the item correctly. These items are unlikely to be useful in discriminating respondent
knowledge due to their relative ease. Next, discrimination indices were calculated for each item.
The sample was divided into two groups based on their total FTDKS score, using cutoffs
recommended by Kline (2005): 27% of the sample who scored lowest (n = 47) and 27% of the
sample who scored highest (n = 48). Scores on the FTDKS ranged from 11 – 32 (M = 25.6, SD =
5.82) for low scorers and 41 – 48 (M = 43.3, SD = 2.01) for high scorers. Individual item
difficulty indices (p) were calculated for both low and high scorers. The difference of these
indices (e.g., phigh-plow) is the discrimination index. A low percentage for the discrimination
index (<10%; Kline, 2005) indicates that the item does not perform differently among the highest
and lowest scoring respondents, suggesting that the item is not helpful in identifying respondents
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with less versus more knowledge. Five items had a discrimination index below 10%, and these
were five of the six items that had a difficulty index above 95%. The sixth item (“People with the
behavioral variant of frontotemporal dementia often act on impulse instead of thinking things
through.”) had a discrimination index of 11%. These six items included two about a FTD
subtype (e.g., behavioral variant). Four different “subtype” items survived item analyses, so the
poorly performing items were removed without losing core content. The other four items were
more broad questions about course and progression and potentially represent core facts about
FTD, but given their low difficulty and discriminability, these items were removed from the final
scale, leaving 18 items.
Properties of the 18-Item FTDKS
On the 18-item FTDKS, the maximum score is 36. In this sample, scores on the FTDKS
ranged from 5 to 36 (M = 24.2, SD = 6.70).
Reliability. Internal consistency reliability (Cronbach’s alpha) was .806, indicating good
internal consistency. Examining individual items, Cronbach’s alpha if an item were deleted
ranged from .789 - .806, and the item-total correlations ranged from .230 - .513 (M = .392, SD =
.075). Therefore, dropping items would not increase alpha substantially. Split-half reliability was
calculated by randomly dividing the scale in half and correlating the items on the first and second
halves, resulting in a Spearman-Brown coefficient of .792.
Validity. Correlations among knowledge indices and respondent characteristics are
shown in Table 3. In terms of predictive validity, FTDKS Total Score should be significantly
associated with variables related to knowledge of FTD. FTDKS Total Score was significantly,
though modestly, correlated with self-rated FTD knowledge, r = .488, p < .001. This significant
association was present within both provider, r = .57, p < .001, and nonprovider subsamples, r =
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.47, p < .001. In terms of convergent validity, performance on the FTDKS should be significantly
associated with performance on other scales that measure related constructs. The correlation
between scores on the FTDKS and scores on the DKAS was .615, p < .001. The correlation
between scores on the FTDKS and general intelligence as measured by the Shipley Vocabulary
Test was .247, p <.05, as would be expected given that the two scales measure distinct
constructs. In terms of concurrent validity, scores on the FTDKS should be significantly
associated with people’s experience with FTD. Among providers, the FTDKS Total Score was
significantly associated with experience treating people with FTD, r = .349, p < .01. Among
nonproviders, FTDKS Total Score was significantly related to level of care provided to people
with FTD, r = .231, p < .05. In an unexpected finding, an independent-samples t-tests revealed
no significant difference on FTDKS performance between providers and nonproviders, t(172) =
1.41, p = .160 (see Table 1 for means). In terms of divergent validity scores on the FTDKS
should not be significantly associated with variables that do not necessarily relate to knowledge
of FTD. Among providers, FTDKS Total Score was not significantly associated with general
experience (years) as a provider, r = .167, p =.178. Among nonproviders, FTDKS Total Score
was not significantly related to number of people with FTD known, r = .190, p = 0.05.
Discussion
This study establishes the reliability and validity of a new scale to measure knowledge
about frontotemporal dementia, the Frontotemporal Dementia Knowledge Scale (FTDKS). The
18-item scale is designed to be used with healthcare providers and caregivers of people with
FTD. It covers general knowledge about FTD, including prevalence, symptoms, course,
treatments, and caregiving. It can be administered in approximately five minutes and uses a
response scale that enable respondents to indicate degrees of certainty about their knowledge. In
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this validation study the scale had good psychometric attributes when evaluated in two samples,
healthcare professionals with varying degrees of experience with FTD and individuals with FTD
caregiving experience. The scale, along with a scoring key and documentation of answers, is
available at http://pages.wustl.edu/geropsychology/ftdks.
Although FTD is less common than Alzheimer’s disease, it is one of the most common
forms of early-onset dementia, and people with FTD and their caregivers incur significant
financial and emotional burden as a result of the disease (Warren et al., 2013). Timely diagnosis
and appropriate care play a critical role in offsetting these costs, and knowledge of FTD among
providers and caregivers increases the likelihood that patients will receive an early and accurate
diagnosis and subsequent support. The FTDKS could be useful in documenting knowledge
among providers and caregivers and could be utilized in steps to develop and evaluate
educational initiatives for these groups.
Several limitations of the study should be noted. First, the scale was evaluated in only
two subsamples, a group of FTD professionals and a group of individuals with FTD caregiving
experience. We do not have evidence of how the scale would perform in other groups, such as
people diagnosed with FTD or the general public. Additional research could verify the
psychometric properties of the scale in other groups. Second, in a somewhat unexpected finding,
we did not find a significant difference in FTDKS scores between our subsamples, indicating
that, on average, providers and nonproviders were equally knowledgeable about FTD. It may be
that because we recruited caregivers from AFTD support groups, they are especially involved
and educated about the disease, with a level of knowledge equivalent to that of the providers.
Future research with a broader sample, including caregivers of patients soon after diagnosis of
FTD, highly specialized providers, and lay audiences will provide a clearer picture of how
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different groups perform on this measure. Third, because the scale includes some technical
language related to specific FTD facts, it is written at a fairly high grade level. As such, the scale
may be less accessible among individuals with more limited literacy.
Fourth, in creating a scale to measure general knowledge of FTD that can be completed
quickly, concerns about content coverage arose. In our initial pool of 24 items, six were
answered correctly by almost all respondents. These items include two items about an FTD
subtype (e.g., behavioral variant) and four items about general course and progression of the
disease (see lower section of Table 2). We believe that the wording of the two FTD subtype
questions may have been leading, which resulted in the high correct response rate despite the
relatively deep knowledge required to identify the behavioral variant. In contrast, the other four
general items potentially represent core facts about FTD that, while too easy for the current
sample, may nonetheless represent basic common knowledge that could be used to gauge
knowledge in a group that may be less familiar with the disease, such as community dwelling
older adults or recently diagnosed patients and their caregivers.
Moreover, FTD refers to a group of clinical syndromes caused by frontotemporal lobar
degeneration (FTLD), so a general scale about FTD will necessarily leave some specifics out.
For example, items about some FTD subtypes, genetic risk factors, and the biological
progression of the disease were not included because they were often too specific to have a
universally accepted answer across the FTD spectrum. Different types of FTD progress at
different rates, under different mechanisms, and with different symptoms and outcomes. Instead,
the FTDKS includes items designed to reflect general knowledge of FTD, and the scale is not
meant as an exhaustive measure of FTD. Likewise, as the scientific community continues to
discover new facts and revise old ones regarding the disease, the FTDKS will require revision.
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At the moment, however, the FTDKS is a reliable and valid scale of FTD knowledge across a
range of domains relevant to healthcare provider and caregivers.
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Table 1
Characteristics of Respondents
Total (n =
174)

Providers (n =
72)

Non-Providers (n =
102)

Characteristic

M/n SD/% M/n

SD/%

M/n

SD/%

Age (years)

51.5

15.7

42.5

12.7

57.8

12.5

Female

133

76.4

58

80.6

75

73.5

White

157

90.2

60

83.3

97

95.1

High School

5

2.9

0

0.0

5

4.9

Some college

17

9.8

0

0.0

17

16.7

Associate degree

7

4.0

3

4.2

4

3.9

Bachelor’s degree

45

25.9

4

5.6

41

40.2

Master’s degree

40

23.0

14

19.4

26

25.5

Doctoral degree

60

34.5

51

70.8

9

8.8

None

4

5.6

A little

17

23.6

Some

18

25.0

A lot

18

25.0

Extensive

10

13.9

0-1

7

9.7

2-4

15

20.8

5-7

7

9.7

8-10

7

9.7

More than 10

31

43.1

Geriatrician

13

18.1

Primary care physician

2

2.8

Psychologist

31

43.1

Education

Professional experience with FTD

Years of experience as a provider

Professional discipline/specialty

22

Neurologist
Registered nurse/Nurse
practitioner
Other

5

6.9

9

12.5

12

16.7

Number of people with FTD known

5.20

1.78

Never been involved in care

10

9.8

Helped arrange for care

2

2.0

Assisted in caregiving

16

15.7

Primary caregiver

74

72.5

Level of care provided

FTDKS Total Score

24.1

6.70

25.0

5.47

23.5

7.40

Self-rated FTD knowledge

7.07

1.79

6.96

1.78

7.16

1.80

DKAS Total Score

35.9

6.94

40.3

6.36

35.3

6.84

Shipley Institute of Living Scale

34.9

3.08

35.1

2.85

34.9

3.13

Note. FTD = frontotemporal dementia; FTDKS = Frontotemporal Dementia Knowledge Scale;
DKAS = Dementia Knowledge Assessment Scale.
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Table 2
Item Characteristics of the Frontotemporal Dementia Knowledge Scale
Item Statement
True or
Probably
Don’t
Difficulty
False
True or
Know
Index (p)
False
1
Frontotemporal
89.33%
10.11%
0.56%
93.82%
dementia is a type of
Alzheimer disease.
(F)

Discrimination
Index
19%

Item-Total Alpha if
Correlation item
dropped
.499
.793

2

For the majority of
people with
frontotemporal
dementia, symptoms
appear before they
are 65 years old. (T)

71.35%

23.04%

5.62%

83.71%

32%

.513

.789

3

Among all people
with dementia, 510% of them have
frontotemporal
dementia. (F)

40.45%

46.07%

13.48%

78.09%

36%

.389

.796

4

People in their
thirties can develop
symptoms of
frontotemporal
dementia. (T)

71.34%

25.28%

3.37%

88.20%

30%

.423

.795

5

Memory loss is a
major symptom of
frontotemporal
dementia. (F)

72.48%

26.97%

0.56%

72.47%

45%

.435

.793

6

Frontotemporal
dementia can be
passed down from
parent to child. (T)

63.48%

26.97%

9.55%

68.54%

55%

.481

.790

7

Among people under
60 years old,
frontotemporal
dementia is about as
common as
Alzheimer disease.
(T)

43.26%

37.08%

19.66%

41.57%

48%

.299

.802

8

The results of a brain
scan by itself can tell
you whether a person
has frontotemporal
dementia. (F)

69.67%

28.66%

1.69%

88.20%

23%

.404

.796

9

People with
frontotemporal
dementia do best
when given choices
among many options.
(F)

75.28%

19.66%

5.06%

87.08%

26%

.331

.800
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10

There are treatments
to slow down
frontotemporal
dementia. (F)

78.09%

21.35%

0.56%

92.70%

15%

.432

.795

11

After symptoms of
frontotemporal
dementia appear, the
average life
expectancy is 7 to 13
years. (T)

55.06%

38.20%

6.74%

82.02%

17%

.298

.802

12

Based on their age,
people who are 70
years old are more
likely to develop
frontotemporal
dementia than people
who are 50 years old.
(F)

57.31%

31.47%

11.24%

75.28%

45%

.476

.791

13

On average,
caregivers of people
with frontotemporal
dementia report more
stress than caregivers
of people with other
dementias. (T)

48.88%

35.96%

15.17%

74.72%

45%

.318

.801
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14

Medications designed 68.54%
to improve memory
and thinking in
people with
Alzheimer disease are
also appropriate for
people with
frontotemporal
dementia. (F)

22.48%

8.99%

86.52%

28%

.395

.796

15

The language variant
of frontotemporal
dementia is more
common than the
behavioral variant.
(F)

38.20%

29.22%

32.58%

55.06%

47%

.336

.800

16

People with the
behavioral variant of
frontotemporal
dementia have
difficulty
remembering events
from the past. (F)

55.62%

34.27%

10.11%

68.54%

56%

.391

.796

17

People with the
61.24%
behavioral variant of
frontotemporal
dementia lack interest
in things they used to
find enjoyable. (T)

30.34%

8.43%

84.83%

28%

.412

.795
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18

People with the
62.36%
29.78%
7.87%
language variant of
frontotemporal
dementia are able to
read and write
without difficulty. (F)
Items removed from the final scale

80.90%

17%

Frontotemporal
97.19%
dementia is a disorder
that causes a decline
in a person’s
behavior or language.
(T)

2.25%

0.56%

99.44%

2%

There are different
forms of
frontotemporal
dementia that lead to
different major
symptoms. (T)

92.69%

7.30%

0.00%

96.63%

9%

After an initial period
of decline, people
with frontotemporal
dementia do not
experience further
change in their
symptoms. (T)

93.26%

6.18%

0.56%

99.44%

2%
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.230

.806

When people with
frontotemporal
dementia act
inappropriately, you
can get them to stop
by explaining why
they should not do it.
(F)

85.95%

12.92%

1.12%

96.07%

9%

People with the
behavioral variant of
frontotemporal
dementia often act on
impulse instead of
thinking things
through. (T)

89.32%

8.42%

2.25%

95.51%

11%

People with the
language variant of
frontotemporal
dementia have
difficulty in spoken
conversations. (T)

87.08%

10.11%

2.81%

97.19%

6%

29

Table 3
Correlations Among Major Study Variables
1

2

3

4

5

6

7

8

1. FTDKS

–

2. DKAS

.615**

3. Self-Rated FTD Knowledge

.488**

.450** –

4. Shipley Institute of Living Scale

.247*

.256*

.075

5. Professional experience with FTDa

.349**

.334

.634** -.036

–

6. Years of experience as a providera

.161

.530

.384** -.292

.327**

–

7. Level of care providedb

.231*

.085

.187

.086

-

-

–

.213

.371**

.165

-

-

-.167 –

8. Number of people with FTD knownb .179

–
–

Note. FTDKS = Frontotemporal Dementia Knowledge Scale; DKAS = Dementia Knowledge Assessment Scale; FTD =
frontotemporal dementia.
a
Provider only
b
Non-provider only
* p < 0.05. ** p < 0.01.
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